150 related articles for article (PubMed ID: 31503380)
1. Cyclin D1 immunohistochemical expression and somatic mutations in canine oral melanoma.
Zamboni C; Brocca G; Ferraresso S; Ferro S; Sammarco A; Dal Corso C; Iussich S; de Andres PJ; Martìnez de Merlo EM; Cavicchioli L; Zappulli V; Castagnaro M
Vet Comp Oncol; 2020 Jun; 18(2):231-238. PubMed ID: 31503380
[TBL] [Abstract][Full Text] [Related]
2. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
[TBL] [Abstract][Full Text] [Related]
3. The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions.
Lebe B; Pabuççuoğlu U; Ozer E
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):160-4. PubMed ID: 17525627
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of somatic focal amplifications on chromosome 30 in canine oral melanoma.
Prouteau A; Chocteau F; de Brito C; Cadieu E; Primot A; Botherel N; Degorce F; Cornevin L; Lagadic MA; Cabillic F; de Fornel-Thibaud P; Devauchelle P; Derrien T; Abadie J; André C; Hédan B
Vet Comp Oncol; 2020 Jun; 18(2):214-223. PubMed ID: 31461207
[TBL] [Abstract][Full Text] [Related]
5. Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M
Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859
[TBL] [Abstract][Full Text] [Related]
6. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
[TBL] [Abstract][Full Text] [Related]
7. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor.
Ozaki K; Yamagami T; Nomura K; Narama I
J Vet Med Sci; 2007 Nov; 69(11):1117-21. PubMed ID: 18057825
[TBL] [Abstract][Full Text] [Related]
9. The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma.
Kaufmann C; Kempf W; Mangana J; Cheng P; Emberger M; Lang R; Kaiser AK; Lattmann E; Levesque M; Dummer R; Koelblinger P
Histopathology; 2020 Sep; 77(3):460-470. PubMed ID: 32374893
[TBL] [Abstract][Full Text] [Related]
10. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
11. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
Han JI; Kim Y; Kim DY; Na KJ
Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
[TBL] [Abstract][Full Text] [Related]
12. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
13. An update on the implications of cyclin D1 in oral carcinogenesis.
Ramos-García P; Gil-Montoya JA; Scully C; Ayén A; González-Ruiz L; Navarro-Triviño FJ; González-Moles MA
Oral Dis; 2017 Oct; 23(7):897-912. PubMed ID: 27973759
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma.
Guillén A; Stiborova K; Ressel L; Blackwood L; Finotello R; Amores-Fuster I; Jama N; Killick D
Res Vet Sci; 2021 Jul; 137():226-234. PubMed ID: 34023546
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
Nazar M; Naz I; Mahmood MK; Hashmi SN
Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
[TBL] [Abstract][Full Text] [Related]
18. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U
Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR.
Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C
Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125
[TBL] [Abstract][Full Text] [Related]
20. Significance of cytoplasmic cyclin D1 expression in oral oncogenesis.
Ramos-García P; Bravo M; González-Ruiz L; González-Moles MÁ
Oral Dis; 2018 Mar; 24(1-2):98-102. PubMed ID: 29480608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]